Umbrella Labs Cagrilintide Peptide Research Use Only Program Expands Laboratory Access For High Rigor Amylin Receptor, Calcitonin Receptor, And Neuroendocrine Signaling Bench Science

February 2, 2026 5:20 AM

Umbrella Labs today announced an expanded research procurement program for cagrilintide peptide to support laboratories running amylin receptor complex profiling, calcitonin receptor signaling studies, and neuroendocrine pathway mapping in controlled bench environments. The program is built for repeatability and documentation discipline, with stable catalog references, batch traceability, and specification forward listings intended to support...

Read more

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

January 31, 2026 8:00 AM

Black Book Research today announced the publication of its position statement, "Market Research Integrity and Insight in the AI Era," establishing a comprehensive framework to safeguard survey, polling, and satisfaction-based research against emerging risks accelerated by generative AI while using AI responsibly to improve research operations without compromising the truth source of benchmark findings.Generative AI is simultaneously increasing...

Read more

Janice Crowder, MD, Calls for Action to Reduce Maternal Mortality

January 30, 2026 4:30 PM

Janice Crowder, MD, a board-certified obstetrician-gynecologist with more than 3 decades of experience, is speaking out to raise awareness of maternal mortality and the practical steps individuals can take to reduce risk before, during, and after pregnancy.Maternal mortality remains a serious public health issue in the United States. The U.S. continues to have one of the highest maternal mortality rates among developed countries. Black women, in...

Read more

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

January 30, 2026 2:25 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, and FORME brands, today published a comprehensive summary of the Sportstech transaction, including source materials and SEC filings, on its website.Trent Ward, Founder and CEO, stated: "We are not sure why Sportstech feels the need to issue press releases targeted towards public-market investors, given...

Read more

Science And Medicine Group Announces Two New Radiology Podcast Series On AuntMinnie.com

January 30, 2026 10:30 AM

Science and Medicine Group (SMG) and AuntMinnie.com have launched two new series of podcasts focused on women's imaging and ultrasound topics.Available today, the inaugural episode (link here) for the Women's Imaging MinnieCast series features a wide-ranging video interview with Amy Patel, MD, on "radvocacy" and how radiologists can make a difference.In addition, the first episode in the Ultrasound MinnieCast series includes a conversation with...

Read more

Understanding When to Use Fillers or Neurotoxins According to Dr. Ran Rubinstein

January 30, 2026 9:00 AM

Injectable aesthetic treatments continue to grow in popularity, yet confusion remains around when dermal fillers are appropriate versus when neurotoxins are the better option. Facial plastic surgeon and national injectables trainer Dr. Ran Rubinstein emphasizes that understanding how these treatments differ is essential to achieving natural, balanced results.As a board-certified facial plastic surgeon certified by the American Board of Facial...

Read more

Genflow Biosciences PLC Announces Holding(s) in Company

January 30, 2026 8:25 AM

TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of registered office (if applicable)rickmansworthCountry of registered office (if applicable)United Kingdom4. Details of the shareholderFull name of...

Read more

Dr. David Berman to Join Moderna as Chief Development Officer

January 30, 2026 7:30 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company's Chief Development Officer, beginning March 2, 2026. He will serve on Moderna's Executive Committee and report to Chief Executive Officer Stéphane Bancel. Dr. Jacqueline Miller will step down as Chief Medical Officer and member of the Executive Committee effective the same date and will remain as a consultant to the Company to assist...

Read more

Esteworld Turkey Highlights Expertise of Medical Director Dr. Burak Tuncer

January 30, 2026 7:20 AM

Esteworld Turkey has continued to expand structured medical services across aesthetic and reconstructive procedures under the clinical leadership of Medical Director Dr. Burak Tuncer. With a background in plastic, reconstructive, and aesthetic surgery, Dr. Burak Tuncer oversees treatment protocols, surgical standards, and multidisciplinary coordination at Esteworld Turkey, with a particular focus on procedures involving the Breast, including...

Read more

How to Choose the Right Pharmacy Services Partner: Key Criteria for Hospitals & Health Systems

January 29, 2026 5:15 PM

In an era where staffing shortages, cost containment, and regulatory complexity challenge healthcare operations, pharmacy support offers hospitals and health systems a strategic advantage. But selecting the right partner is more than a logistical decision - it's a critical investment in patient safety, operational efficiency, and compliance. For rural hospitals, community health centers, specialty clinics, and integrated health systems, the...

Read more

Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)

January 29, 2026 5:00 PM

Moderna, Inc. (NASDAQ:MRNA) today announced a strategic collaboration with Recordati to advance Moderna's investigational propionic acidemia (PA) therapeutic, mRNA-3927, through the final stages of clinical development and, upon approval, global commercialization. Recordati, based in Milan, Italy, is an international pharmaceutical group that provides treatments across specialty and primary care, and rare diseases, including PA. Through this...

Read more

Pharma-Bio Serv Announces Full Year Results and Special Dividend

January 29, 2026 5:00 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, today announced that revenues for the year ended October 31, 2025 were approximately $9.0 million, a decrease of approximately $0.5 million...

Read more

Pro-Dex, Inc. Announces Fiscal 2026 Second Quarter and Six-Month Results

January 29, 2026 4:00 PM

PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2026 with the Securities and Exchange Commission today.Quarter Ended December 31, 2025Net sales for the three months ended December 31, 2025, increased $1.9 million, or 11%, to $18.7 million from $16.8 million for the three months...

Read more

Medical Component Specialists to Exhibit at MD&M West 2026 - Booth #3277

January 29, 2026 1:25 PM

Medical Component Specialists (MCS) will be exhibited at booth #3277, during MD&M West 2026, taking place February 3-5 at the Anaheim Convention Center in Anaheim, California. The event brings together leaders, suppliers, and innovators from across the advanced manufacturing industry and is recognized as one of the most comprehensive manufacturing trade shows in North America.MD&M West unites five interconnected sectors, MedTech, Automation,...

Read more

LIV Recovery Center Expands Focus on Dual Diagnosis Treatment

January 29, 2026 11:00 AM

LIV Recovery Center, a behavioral and mental health treatment clinic located in Alpharetta, Georgia, is advancing its dual diagnosis treatment services to better serve the needs of individuals with co-occurring mental health and substance use disorders. The effort is part of a larger shift toward integrated dual diagnosis care, and is proven to support long-term wellness and stronger recovery outcomes.A dual diagnosis, or diagnosis of...

Read more

BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple

January 29, 2026 10:50 AM

BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, announced today that it will launch a GLP-1 test panel at over 25 Austin and Temple BetterWay collection locations including Sam's Club and Peoples Rx pharmacies-pairing GLP-1 prescriptions, including Wegovy's new oral GLP-1 option, with BetterWay's patient-preferred fingertip blood collection.The FDA's recent...

Read more

When Wildfires Strike: The Vital Role of Continuous Care and Community

January 29, 2026 10:30 AM

January 2026 marks one year since Eaton Canyon wildfires swept across the Los Angeles area of California, leaving a trail of destruction and uncertainty in their wake. Amid the chaos of the fires, the importance of reliable and continuous healthcare became clear, especially for people relying on life-sustaining treatments like dialysis.For DaVita, the commitment to patients and teammates (employees) never wavered. When the fires threatened...

Read more

The Longevity Centers of America Introduces Minimally Invasive NanoScope Needle Arthroscopy for Joint Pain Relief

January 29, 2026 10:00 AM

The Longevity Centers of America (LCOA) has expanded its regenerative medicine capabilities with the introduction of NanoScope Needle Arthroscopy. This advanced diagnostic technology allows patients to receive same-day joint evaluation and treatment without traditional surgical incisions. The minimally invasive system offers a new option for individuals experiencing persistent joint pain, suspected cartilage damage, or unexplained...

Read more

Rural Hospitals Don't Need More Beds - They Need Smarter Capacity, Like Mobile ICUs

January 29, 2026 9:12 AM

VSee Health (Nasdaq:VSEE), a leader in innovative telehealth technology, today announced it will be hosting a live webinar, "The On‑Demand ICU: Sustainable Rural Healthcare," February 4, 2026, 11:00 AM PT / 2:00 PM ETRural hospitals are under pressure like never before. Rising patient acuity, chronic staffing shortages, and limited access to intensivists are forcing facilities to transfer high‑acuity patients-and leave critical revenue on the...

Read more

Encision Deregisters Common Stock

January 29, 2026 9:00 AM

Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced today that its Board of Directors approved the filing of a Form 15 with the Securities and Exchange Commission ("SEC") to voluntarily deregister its common stock under Section 12(g) of the Securities Exchange Act of 1934 ("the Exchange Act"). ...

Read more